UCLA Hematology/Oncology Parkside — Santa Monica, California

UCLA Hematology/Oncology Parkside is a clinical research site located in Santa Monica, California, United States 90404.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Hematology/Oncology Parkside has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, HER2 Positive Breast Cancer, HER2+/HR+ Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Jazz Pharmaceuticals, G1 Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology/Oncology Parkside?

UCLA Hematology/Oncology Parkside has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology/Oncology Parkside conducted?

UCLA Hematology/Oncology Parkside has 6 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, HER2 Positive Breast Cancer, HER2+/HR+ Breast Cancer.

Is UCLA Hematology/Oncology Parkside accredited by Crixeo Health?

UCLA Hematology/Oncology Parkside has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematology/Oncology Parkside?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.